Effectiveness of palliative photodynamic therapy for unresectable biliary cancer. Systematic review and meta-analysis

Author:

Tseimakh A. E.1,Mitshenko A. N.2,Kurtukov V. A.2,Shoykhet Ia. N.1,Kuleshova I. V.1

Affiliation:

1. Altai State Medical University

2. State hospital №5

Abstract

A systematic review and meta-analysis was aimed to assess the effectiveness of palliative photodynamic therapy for unresectable malignant tumors of the biliary system in order to justify the feasibility of including photodynamic therapy (PDT) in the complex treatment of this category of patients. Publications in the databases PubMed Central, the bibliographic database of scientifi citations of the RSCI, and the Cochrane library were considered. Heterogeneity was assessed graphically using forest plots and statistically using tau2 and I2 statistics. A meta-analysis of 5-year survival revealed a statistically signifiantly longer pooled estimate of the survival period in groups where PDT was used – 339±161 days (95% CI 25-710; p < 0.001) compared to groups where PDT was not used – 83±16 days (95% CI 33-100; p < 0.001). Heterogeneity among studies was found to be statistically insignifiant (I2 = 29%, p = 0.23). A meta-analysis of the risk difference for adverse events revealed a statistically signifiantly lower risk (-0.2306; 95% CI -0.3917-0.0696; p = 0.005) of adverse events after PDT compared with the comparison group. Heterogeneity among studies was found to be statistically insignifiant (I2 = 0%, p = 0.35). There were no signifiant publication biases in either meta-analysis. The presented meta-analysis demonstrated that PDT may be the method of choice in the palliative complex treatment of patients with unresectable cholangicarcinomas, increasing the ˝ve-year survival of patients along with the absence of increased risks of postoperative complications in comparison with other methods of palliative surgical treatment.

Publisher

Russian Photodynamic Association

Reference26 articles.

1. The state of oncological care for the population of Russia in 2020 / edited by Kaprin A.D., Starinsky V.V., Petrova G.V. M.: Herzen Moscow State Medical Research Institute – branch of the Federal State Budgetary Institution «NMIRC» of the Ministry of Health of Russia, 2021, pp. 239.

2. Zhang X. et al. Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update. Intractable Rare Dis Res, 2022, vol. 11(4), pp. 161-172.

3. All-Russian National Union «Association of Oncologists of Russia». Cancer of the biliary system. Clinical recommendations, 2020, p. 51.

4. Zеrеm Е., Imširоvić B., Kunоsić S. еt аl. Pеrcutаnеоus biliаry drаinаgе fоr оbstructivе jаundicе in pаtiеnts with inоpеrаblе, mаlignаnt biliаry оbstructiоn. Clin Еxp Hеpаtоl, 2022, vol. 8(1), рр. 70-77.

5. Shаh R., Jоhn S. Chоlеstаtic Jаundicе. In: StаtPеаrls [Intеrnеt]. Trеаsurе Islаnd (FL): StаtPеаrls Publishing, 2022, PMID: 29489239.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3